MiMedx Group MDXG Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $389.42M-7.0% | $418.63M+6.4% | $393.44M+8.2% | $363.77M+3.2% | $352.38M+1.0% | ||
| $73.82M+1.1% | $73.01M+3.0% | $70.87M+5.0% | $67.47M+6.0% | $63.64M+5.9% | ||
| $315.59M-8.7% | $345.62M+7.1% | $322.58M+8.9% | $296.3M+2.6% | $288.73M0.0% | ||
| 81%-1.5pp | 82.6%+0.6pp | 82%+0.5pp | 81.5%-0.5pp | 81.9%-0.8pp | ||
| $15.91M+5.4% | $15.1M+8.6% | $13.91M+6.0% | $13.12M+2.3% | $12.83M+3.9% | ||
| $259.46M-2.5% | $266.19M+4.7% | $254.16M+6.5% | $238.68M+3.8% | $229.93M+2.2% | ||
| $39.59M-38.0% | $63.89M+18.6% | $53.87M+25.7% | $42.84M-20.6% | $53.92M-8.4% | ||
| 10.2%-5.1pp | 15.3%+1.6pp | 13.7%+1.9pp | 11.8%-3.5pp | 15.3%-1.6pp | ||
| $3.31M+13.0% | $2.93M— | —— | —— | —— | ||
| -$581K-4.1% | -$558K+3.8% | -$580K-22.1% | -$475K+22.3% | -$611K-8.1% | ||
| $42.32M-36.1% | $66.26M+18.9% | $55.72M+25.8% | $44.29M-18.7% | $54.5M-4.9% | ||
| $11.62M-34.3% | $17.68M+18.8% | $14.89M+20.8% | $12.33M-15.2% | $14.54M-5.0% | ||
| $0.20-37.5% | $0.32+18.5% | $0.27+28.6% | $0.21-22.2% | $0.27-3.6% | ||
| $51.05M-35.2% | $78.77M+18.4% | $66.54M+24.8% | $53.3M-14.3% | $62.17M-4.2% | ||
| 13.1%-5.7pp | 18.8%+1.9pp | 16.9%+2.3pp | 14.7%-3.0pp | 17.6%-1.0pp | ||
| $39.59M-38.0% | $63.89M+18.6% | $53.87M+25.7% | $42.84M-20.6% | $53.92M-8.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is MiMedx Group's revenue?
- MiMedx Group (MDXG) generated $389.4M in revenue over the trailing twelve months, up 10.5% year over year.
- Is MiMedx Group profitable?
- MiMedx Group reported $30.7M in net income over the trailing twelve months, a 7.9% net margin.
- What are MiMedx Group's profit margins?
- Gross margin is 81.0% and operating margin is 10.2%, with a 7.9% net margin.
- What is MiMedx Group's earnings per share?
- MiMedx Group's diluted EPS over the trailing twelve months is $0.20.
- Where does MiMedx Group's income statement data come from?
- Every line is extracted from MiMedx Group's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
